Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Merck & Co., Inc. Receives Approval for Hypertension Drug Through Billion Dollar Acquisition

January 03, 2025
Merck & Co., Inc. (NYSE: MRK) has received approval from UK regulatory authorities for its hypertension drug, which was acquired through an 11 billion dollar deal with Acceleron Pharma. This drug has shown promising results in clinical trials, leading to its successful market entry. The acquisition of Acceleron Pharma not only strengthens Merck's portfolio but also solidifies its position in the hypertension drug market. With this approval, Merck expects a significant increase in revenue and market share. Experts from Stocks Prognosis recommend investors to consider buying Merck & Co., Inc. shares, as the company is expected to experience positive growth in the near future.
If you want to leave a comment, then you need Login or Register





Other data for MRK

Related data

MRKJune 19, 2025Merck KGaAs ETR:MRK Fundamentals Look Pretty Strong: Could The Market Be Wrong About the Stock?  ~1 min.

MRK Merck & Co., Inc. has recently received FDA approval to expand the use of its top-selling drug Keytruda. This news has led to positive expectations for the company's future performance....

MRKMarch 22, 2025Merck & Co., Inc. (MRK) Tops List of Dividend Contenders  ~1 min.

Merck & Co., Inc. (MRK) has been recognized as one of the top dividend contenders in the market, according to Yahoo Finance....

MRKMarch 19, 2025Merck Co. Inc. MRK: Among Dobermans of the Dow to Buy  ~1 min.

Merck Co. Inc. (MRK) has emerged as a top pick among investors looking for stable and reliable stocks....

MRKMarch 18, 2025Merck & Co. Inc. Urges Shareholders to Join Class Action  ~1 min.

Shareholders that lost money on Merck & Co. Inc. (MRK) are being urged to join a class action against the company....

MRKMarch 16, 2025Merck & Co., Inc.: A Promising Investment Opportunity with Strong Growth Potential  ~2 min.

Merck & Co., Inc., commonly known as Merck, has emerged as one of the most undervalued stocks in the US market, as indicated by leading hedge funds....

MRKMarch 15, 2025Merck & Co. MRK Opens $1B Next-Gen Vaccine Facility in Major US Expansion  ~2 min.

Merck & Co. (MRK), one of the leading pharmaceutical companies, has announced the opening of its state-of-the-art $1 billion Next-Generation Vaccine Facility....

MRKMarch 14, 2025Merck Co. Inc.: Investing in a Strong and Reliable Dividend Stock  ~2 min.

Merck & Co., Inc., commonly known as Merck, is a global healthcare company that develops and markets innovative pharmaceutical, vaccine, biologic, and animal health products....

MRKFebruary 28, 2025Merck MRK to Present Strategic Update at TD Cowen Healthcare Conference  ~2 min.

Merck & Co., Inc. (MRK) is set to present its strategic update at the upcoming TD Cowen Healthcare Conference....

MRKFebruary 27, 2025ROSEN HIGHLY RECOGNIZED INVESTOR COUNSEL Encourages Merck Co. Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action  ~1 min.

Investors of MRK Merck & Co. Inc. have been urged by ROSEN HIGHLY RECOGNIZED INVESTOR COUNSEL to seek legal representation before the critical deadline related to a securities class action....

MRKFebruary 20, 2025MRK MERCK & CO., INC.: A Promising Stock to Consider, According to Experts  ~2 min.

Merck & Co., Inc. (NYSE: MRK) has caught the attention of investors as a potential investment opportunity....

MRKJanuary 5, 2025Merck & Co. Inc.: A Powerhouse in the Pharmaceutical Industry  ~2 min.

Merck & Co. Inc., commonly known as Merck, is a leading multinational pharmaceutical company that has been making waves in the industry....

MRKJanuary 6, 2025Merck & Co., Inc. (MRK): The Next Big Player in the Pharma Industry?  ~2 min.

Merck & Co., Inc. (MRK) is making waves in the pharmaceutical industry with its recent acquisition of Acceleron Pharma....

MRKDecember 1, 2024Merck & Co. Inc. MRK Announces Groundbreaking Cancer Breakthrough  ~2 min.

Merck & Co. Inc. (MRK), one of the leading pharmaceutical companies, has made a major breakthrough in cancer research, according to recent reports....

WFCFebruary 7, 2025Wells Fargo Clears Major Regulatory Hurdles as Fed Terminates Two Legacy Consent Orders  ~1 min.

Wells Fargo & Company (NYSE: WFC) celebrated a significant milestone as the Federal Reserve terminated two longstanding consent orders that had been imposed on the bank in the aftermath of the 2016 fake accounts scandal. The termination comes after the bank implemented extensive reforms and improved its risk management systems. This development highlights Wells Fargo's commitment to restoring its ...

TMOFebruary 26, 2025Solventum Announces Sale of its Purification Filtration Business to Thermo Fisher Scientific Inc. for 4.1B  ~2 min.

Solventum, a leading provider of purification filtration solutions, has announced the sale of its business to Thermo Fisher Scientific Inc. for a staggering amount of 4.1 billion dollars....